Cirata (CRTA) Q2 2026 TU earnings summary

Executive summary

• Raised $7.2 million (£5.4m) in an oversubscribed fundraise, strengthening the balance sheet and supporting growth and product scaling initiatives.

• Achieved strategic expansion of the OEM agreement with IBM and secured the first live deployment of Cirata Symphony with a major UK retailer, with beta trials at a top-three US bank.

• Go-to-market sales team is now fully resourced, supporting increased pipeline activity and new customer acquisition.

• No new customer logos closed in Q2; all ACV growth came from renewals and expansions within the existing customer base.

• Marked three years since the turnaround, with a focus on data orchestration and a foundation for growth.

Financial highlights

• Closing ACV increased to $5.3 million (GBP 5.3 million) in Q2 from $4.9 million (GBP 4.9 million) in Q1, driven by $0.4 million net new ACV from existing customers.

• Unaudited cash balance as of June 30 was $2.6 million (GBP 2.6 million), with cash plus receivables at $2.8 million, excluding $7.2 million gross cash from the fundraise.

• Q2 net cash consumption was $2.1 million, following a weaker Q1 bookings quarter.

• Overheads in Q2 were $3.2 million, consistent with the annualized target range of $12–13 million.

• Billings for Q2FY26 were $0.5 million; Remaining Contract Billings (RCB) stood at $5.7 million.

Outlook and guidance

• Reaffirmed target of cash flow breakeven for FY 2026, supported by cost discipline and a strengthened balance sheet.

• Focus for the second half is on executing disciplined growth and converting pipeline into new customer wins.

• Management priorities include new logo acquisition, customer expansion, and building business model predictability.